VAGIFEM (estradiol)
VAGINAL ESTROGENS · ATROPHY OF VULVA ·+1
NOVO NORDISK
Drug class
Vaginal Estrogens
Vaginal estrogens are a therapeutic class of locally administered hormonal medications formulated as creams, tablets, inserts, or rings. Read more about Vaginal Estrogens
47 drugs in this class 24 manufacturers
Drugs in Vaginal Estrogens
ESTRADIOL
ESTROGENS · FEMALE HYPOGONADISM ·+6
Mylan Pharmaceuticals
ESTRADIOL
ESTROGENS · METASTATIC BREAST CARCINOMA ·+9
Mylan Pharmaceuticals
ESTRADIOL
VAGINAL ESTROGENS · FEMALE HYPOGONADISM ·+6
ALVOGEN INC
ESTRADIOL
ESTROGENS · FEMALE HYPOGONADISM ·+6
Mylan Pharmaceuticals
YUVAFEM (estradiol)
VAGINAL ESTROGENS · ATROPHY OF VULVA ·+1
Amneal Pharmaceuticals
ESTRACE (estradiol)
ESTROGENS · METASTATIC BREAST CARCINOMA ·+9
Allergan
ESTRACE (estradiol)
ESTROGENS · ATROPHY OF VULVA ·+1
Allergan
YUVAFEM (estradiol)
VAGINAL ESTROGENS · ATROPHY OF VULVA ·+1
AVKARE
Filter & compare in the drug finder →
Opens the drug finder with Vaginal Estrogens preselected. Add indication or manufacturer filters there.
Vaginal estrogens are a therapeutic class of locally administered hormonal medications formulated as creams, tablets, inserts, or rings.
They function by activating nuclear estrogen receptors in the urogenital epithelium, which restores mucosal thickness, enhances vaginal elasticity, and normalizes physiological pH with minimal systemic absorption.
This drug class is primarily indicated for the treatment of genitourinary syndrome of menopause (GSM), specifically relieving moderate-to-severe vulvar and vaginal atrophy, dyspareunia, and associated lower urinary tract symptoms or recurrent urinary tract infections.
-
medlineplus.gov
Vaginal estrogens are a therapeutic class of locally administered hormonal medications formulated as creams, tablets, inserts, or rings
-
nih.gov
Vaginal estrogens are a therapeutic class of locally administered hormonal medications formulated as creams, tablets, inserts, or rings They function by activating nuclear estrogen receptors in the urogenital epithelium, which restores mucosal thickness, enhances vaginal elasticity, and normalizes physiological pH with minimal systemic absorption This drug class is primarily indicated for the treatment of genitourinary syndrome of menopause (GSM), specifically relieving moderate-to-severe vulvar...
-
fda.gov
They function by activating nuclear estrogen receptors in the urogenital epithelium, which restores mucosal thickness, enhances vaginal elasticity, and normalizes physiological pH with minimal systemic absorption
-
fda.gov
This drug class is primarily indicated for the treatment of genitourinary syndrome of menopause (GSM), specifically relieving moderate-to-severe vulvar and vaginal atrophy, dyspareunia, and associated lower urinary tract symptoms or recurrent urinary tract infections
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.